Catharina Clarissa Ursia, Patricia Dian Putri


Reciprocity between skin microbiome and the host underlies the occurrence, exacerbation, and severity of atopic dermatitis (AD). However, the role of skin microbiome in the pathogenesis of AD is yet to be depicted. This review highlights the host–microbiome interactions which relies on barrier status, microbiome composition, and microbe–microbe interactions. A microbiome shift, with abundance of S. aureus and lower microbial diversity, compromises the skin barrier function. It goes to show that epidermal barrier defect depletes the protective commensal skin bacteria and demonstrate how dysbiosis of the skin microbiome can lead to AD.

Save to Mendeley


atopic dermatitis, skin microbiome, dysbiosis

Full Text:



Ahn K. The prevalence of atopic dermatitis in Korean children. Allergy Asthma Immunol Res. 2016;8:1–2.

Mortz CG, Andersen KE, Dellgren C, Barington T, Bindslev-Jensen C. Atopic dermatitis from adolescence to adulthood in the TOACS cohort: Prevalence, persistence and comorbidities. Eur. J. Allergy Clin Immunol. 2015 Jul 1;70(7):836–45.

Eckert L, Gupta S, Gadkari A, Mahajan P, Gelfand JM. Burden of illness in adults with atopic dermatitis: analysis of National Health and Wellness Survey data from France, Germany, Italy, Spain, and the United Kingdom. J Am Acad Dermatol. 2019;81:187–95.

Ariëns LFM, van Nimwegen KJM, Shams M, de Bruin DT, van der Schaft J, et al. Economic burden of adult patients with moderate to severe atopic dermatitis indicated for systemic treatment. Acta Derm Venereol. 2019;99(9):762–8.

Leung DYM, Berdyshev E, Goleva E. Cutaneous barrier dysfunction in allergic diseases. J Allergy Clin Immunol. Mosby Inc. 2020;45: 1485–97.

Yamazaki Y, Nakamura Y, Núñez G. Role of the microbiota in skin immunity and atopic dermatitis. Allergology International. JSA. 2017;66: 539–44.

Erin Chen Y, Fischbach MA, Belkaid Y. Skin microbiota-host interactions. Nature. Nature Publishing Group. 2018;553: 427–36.

Byrd AL, Belkaid Y, Segre JA. The human skin microbiome. Nature Reviews Microbiology. Nature Publishing Group; 2018;16:143–55.

Grice EA, Kong HH, Conlan S, Deming CB, Davis J, et al. Topographical and Temporal Diversity of the Human Skin Microbiome. Science AAAS. 2009;324:1190-1192..

Findley K, Oh J, Yang J, Conlan S, Deming C, et al. Topographic diversity of fungal and bacterial communities in human skin. Nature. 2013;498:367–70.

Tsakok T, Woolf R, Smith CH, Weidinger S, Flohr C. Atopic dermatitis: the skin barrier and beyond. Br J Dermatol. Blackwell Publishing Ltd. 2019;180:464–74.

Kim BS, Kim JY, Lim HJ, Lee WJ, Lee SJ, et al. Colonizing features of Staphylococcus aureus in early childhood atopic dermatitis and in mothers: A cross-sectional comparative study done at four kindergartens in Daegu, South Korea. Ann Allergy Asthma Immunol. 2011;106(4):323–29.

Park HY, Kim CR, Huh IS, Jung MY, Seo EY, et al. Staphylococcus aureus colonization in acute and chronic skin lesions of patients with atopic dermatitis. Ann Dermatol. 2013;25(4):410–16.

Bjerre RD, Holm JB, Palleja A, Sølberg J, Skov L, et al. Skin dysbiosis in the microbiome in atopic dermatitis is site-specific and involves bacteria, fungus and virus. BMC Microbiol. 2021;21(1):1-10.

Fyhrquist N, Muirhead G, Prast-Nielsen S, Jeanmougin M, Olah P, et al. Microbe-host interplay in atopic dermatitis and psoriasis. Nat Commun. 2019;10(1):1-12.

Baurecht H, Rühlemann MC, Rodríguez E, Thielking F, Harder I, et al. Epidermal lipid composition, barrier integrity, and eczematous inflammation are associated with skin microbiome configuration. J Allergy Clin Immunol. 2018;141(5):1668-76.

Kong HH, Oh J, Deming C, Conlan S, Grice EA, Beatson MA, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012;22(5):850–59.

Kim J, Kim BE, Leung DYM. Pathophysiology of atopic dermatitis: Clinical implications. AAP. OceanSide Publications Inc.2019;40(2): 84–92.

Pothmann A, Illing T, Wiegand C, Hartmann AA, Elsner P. The Microbiome and Atopic Dermatitis: A Review. Am J Clin Dermatol. Adis; 201;20:749–61.

Williams MR, Gallo RL. Evidence that Human Skin Microbiome Dysbiosis Promotes Atopic Dermatitis. J Invest Dermatol. Elsevier B.V.; 2017;137:2460–63.

Tay ASL, Li C, Nandi T, Chng KR, Andiappan AK, et al. Atopic dermatitis microbiomes stratify into ecologic dermotypes enabling microbial virulence and disease severity. J Allergy Clin Immunol. 2021;147(4):1329–40.

Bjerre RD, Bandier J, Skov L, Engstrand L, Johansen JD. The role of the skin microbiome in atopic dermatitis: a systematic review. Br J Dermatol. Blackwell Publishing Ltd. 2017;177: 1272–78.

Angulo EL, Gern JE. Staphylococcus aureus and staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis. Pediatrics. 2018;142:229–30.

Czarnowicki T, Krueger JG, Guttman-Yassky E. Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march. J Allergy Clin Immunol. Mosby Inc. 2017;139:1723–34.

Teruaki Nakatsuji, Tiffany H. Chen, Saisindhu Narala. Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci. Transl. Med. 2017;9:1–11.

Shi B, Leung DYM, Taylor PA, Li H. Methicillin-Resistant Staphylococcus aureus Colonization Is Associated with Decreased Skin Commensal Bacteria in Atopic Dermatitis. J Invest Dermatol. 2018;138(7):1668–71.

Ong PY, Leung DYM. Bacterial and Viral Infections in Atopic Dermatitis: a Comprehensive Review. Clin Rev Allergy Immuno. Humana Press Inc.; 2016;51:329–37.

Kobayashi T, Glatz M, Horiuchi K, Kawasaki H, Akiyama H et al. Dysbiosis and Staphyloccus aureus Colonization Drives Inflammation in Atopic Dermatitis. Immunity. 2015;42(4):756–66.

Nakatsuji T, Chen TH, Two AM, Chun KA, Narala S, et al. Staphylococcus aureus Exploits Epidermal Barrier Defects in Atopic Dermatitis to Trigger Cytokine Expression. J Invest Dermatol. 20162;136(11):2192–2200.

Wollenberg A, Christen-Zäch S, Taieb A, Paul C, Thyssen JP, et al. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children. J Eur Acad Dermatol Venereol. 2020;34(12):2717–44.

Lai Y, di Nardo A, Nakatsuji T, Leichtle A, Yang Y, et al. Commensal bacteria regulate toll-like receptor 3-dependent inflammation after skin injury. Nat Med. 2009;15(12):1377–82.

Francuzik W, Franke K, Schumann RR, Heine G, Worm M. Propionibacterium acnes abundance correlates inversely with staphylococcus aureus: Data from atopic dermatitis skin microbiome. Acta Derm Venereol. 2018;98(5):490–95.

Wang Y, Dai A, Huang S, Kuo S, Shu M, et al. Propionic acid and its esterified derivative suppress the growth of methicillin-resistant Staphylococcus aureus USA300. Benefic Microbes. 2014;5(2):161–68.

Chng KR, Tay ASL, Li C, Ng AHQ, Wang J, et al. Whole metagenome profiling reveals skin microbiome-dependent susceptibility to atopic dermatitis flare. Nat Microbiol. 2016;1(9):1-9.

Moosbrugger-Martinz V, Hackl H, Gruber R, Pilecky M, Knabl L, Orth-Höller D, et al. Initial Evidence of Distinguishable Bacterial and Fungal Dysbiosis in the Skin of Patients with Atopic Dermatitis or Netherton Syndrome. J Invest Dermatol. 2021;141(1):114–23.

Kim JE, Kim HS. Microbiome of the skin and gut in atopic dermatitis (Ad): Understanding the pathophysiology and finding novel management strategies. J Clin Med. 2019;8(4):1-5.

Iwamoto K, Moriwaki M, Miyake R, Hide M. Staphylococcus aureus in atopic dermatitis: Strain-specific cell wall proteins and skin immunity. International. JSA. 2019;68:309–15.

Berdyshev E, Goleva E, Bronova I, Dyjack N, Rios C, et al. Lipid abnormalities in atopic skin are driven by type 2 cytokines. JCI Insight. 2018;3:1-13.

Goleva E, Berdyshev E, Leung DYM. Epithelial barrier repair and prevention of allergy. Journal of Clinical Investigation. J Clin Invest. 2019;129:1463–74.

Leung DYM, Guttman-Yassky E. Deciphering the complexities of atopic dermatitis: Shifting paradigms in treatment approaches. J Allergy Clin Immunol. Mosby Inc.; 2014;134:769–79.

Clausen ML, Edslev SM, Andersen PS, Clemmensen K, Krogfelt K, et al. Staphylococcus aureus colonization in atopic eczema and its association with filaggrin gene mutations. Br J Dermatol. 2017;177(5):1394–400.

Miajlovic H, Fallon PG, Irvine AD, Foster TJ. Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus. J Allergy Clin Immunol. 2010;126(6):1184-88.

Geoghegan JA, Irvine AD, Foster TJ. Staphylococcus aureus and Atopic Dermatitis: A Complex and Evolving Relationship. Trends in Microbiology. Elsevier Ltd; 2018;26: 484–97.

McAleer MA, Irvine AD. The multifunctional role of filaggrin in allergic skin disease. J Allergy Clin Immunol. 2013; 131: 280–91.

Kim BE, Leung DYM. Significance of skin barrier dysfunction in atopic dermatitis. Allergy, Asthma and Immunology Research. Korean Academy of Asthma, Allergy and Clinical Immunology. 2018;10: 207–15.

Li S, Villarreal M, Stewart S, Choi J, Ganguli-Indra G, et al. Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in atopic dermatitis. Br J Dermatol. Blackwell Publishing Ltd. 2017;177:125–7.

Stalder JF, Fluhr JW, Foster T, Glatz M, Proksch E. The emerging role of skin microbiome in atopic dermatitis and its clinical implication. J Dermatolog Treat. Taylor and Francis Ltd. 2019;30:357–64.

Zhu TH, Zhu TR, Tran KA, Sivamani RK, Shi VY. Epithelial barrier dysfunctions in atopic dermatitis: a skin–gut–lung model linking microbiome alteration and immune dysregulation. Br J Dermatol. Blackwell Publishing Ltd. 2018;179:570–81.

Ljm Zeeuwen P, Boekhorst J, van den Bogaard EH, de Koning HD, Mc Van De Kerkhof P, et al. Microbiome dynamics of human epidermis following skin barrier disruption. Genome Biol. 2012; 13(11): 1-15.

Wollina U. Microbiome in atopic dermatitis. Clin Cosmet Investig Dermatol. Dove Medical Press Ltd.2017;10:51–6.

Nakatsuji T, Gallo RL. The role of the skin microbiome in atopic dermatitis. Ann Allergy Asthma Immunol. American College of Allergy, Asthma and Immunology; 2019;122:263–69.

Mallbris L, Carlén L, Wei T, Heilborn J, Nilsson MF, et al. Injury downregulates the expression of the human cathelicidin protein hCAP18/LL-37 in atopic dermatitis. Exp Dermatol. 2010;19(5):442–49.

Tankersley A, Frank MB, Bebak M, Brennan R. Early effects of Staphylococcus aureus biofilm secreted products on inflammatory responses of human epithelial keratinocytes. J Inflamm. 2014; 11(17): 1-10.

Williams MR, Nakatsuji T, Gallo RL. Staphylococcus aureus: Master Manipulator of the Skin. Cell Host Microbe. Cell Press. 2017;22: 579–81.

Brauweiler AM, Goleva E, Leung DYM. Interferon-γ Protects from Staphylococcal Alpha Toxin-Induced Keratinocyte Death through Apolipoprotein L1. J Invest Dermatol. 2016;136(3):658–64.

Leung DYM. The microbiome and allergic diseases: A struggle between good and bad microbes. Ann Allergy Asthma Immunol. 2019;122(3):231–2.